Dr Mike Morton recently attended the Ion Channel Modulation Symposium at Clare College, Cambridge. The symposium brings together 200 scientists from academia, industry, CROs and academic drug discovery with lectures on diverse topics such as the role of ion channels in metastatic cancer, pain, and epilepsy. The symposium is organised by Sophion, makers of the QPatch instrument, used by ApconiX to deliver our CIPA ion channel assays.
Share This Story, Choose Your Platform!
About the Author: Ruth Roberts
Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.
